Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
CHINA OILFIELD
02883
5
CNOOC
00883
CN Stock MarketDetailed Quotes
Shenzhen Kangtai Biological Products (300601)
- 14.04
- -0.23-1.61%
Market Closed Apr 24 15:00 CST
15.68BMarket Cap192.33P/E (TTM)
14.36High14.04Low153.64KlotVolume14.27Open14.27Prev Close217.52MTurnover1.71%Turnover Ratio222.86P/E (Static)1.12BShares21.1252wk High1.71P/B12.64BFloat Cap13.0052wk Low17.12Limit Up900.37MShs Float154.68Historical High11.42Limit Down2.24%Range %0.21Historical Low0.09Dividend TTM14.16Avg Price84.90KlotAsk0.64%Div Yield TTM100Lot Size63.11KlotBid
Shenzhen Kangtai Biological Products (300601) Income Statement
All
YOY
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -2.18%631.11M | 0.81%2.67B | 2.24%2.06B | 15.81%1.39B | 42.85%645.2M | -23.75%2.65B | -18.11%2.02B | -30.54%1.2B | -39.65%451.66M | 10.14%3.48B |
| Operating revenue | -2.18%631.11M | 0.81%2.67B | 2.24%2.06B | 15.81%1.39B | 42.85%645.2M | -23.75%2.65B | -18.11%2.02B | -30.54%1.2B | -39.65%451.66M | 10.14%3.48B |
| Other operating revenue | ---- | 36.94%12.17M | ---- | 34.45%3.96M | ---- | -18.49%8.88M | ---- | 161.65%2.95M | ---- | -61.23%10.9M |
| Total operating cost | 0.83%599.37M | 8.84%2.5B | 20.52%1.93B | 27.76%1.29B | 41.46%594.45M | -10.43%2.3B | -7.79%1.6B | -14.28%1.01B | -16.40%420.22M | -1.84%2.57B |
| Operating cost | 6.50%182.4M | 41.72%676.61M | 61.74%540.26M | 71.67%334.79M | 137.99%171.26M | -11.21%477.42M | -2.85%334.02M | -14.98%195.01M | -31.75%71.96M | 7.55%537.67M |
| Operating tax surcharges | 70.86%6.96M | 18.15%36.1M | 26.26%22.05M | 32.98%18.16M | 47.35%4.07M | 19.27%30.55M | 14.97%17.46M | 17.85%13.66M | -33.70%2.76M | 25.02%25.62M |
| Operating expense | 11.10%231.13M | 0.80%894.39M | 3.00%691.52M | 18.48%470.24M | 30.22%208.03M | -27.95%887.25M | -20.59%671.4M | -33.46%396.9M | -38.37%159.76M | 13.36%1.23B |
| Administration expense | -14.10%71.66M | -16.32%311.42M | -7.15%227.14M | -9.38%158.52M | 13.48%83.42M | 35.06%372.14M | 42.76%244.62M | 74.85%174.93M | 42.33%73.52M | 19.70%275.53M |
| Financial expense | 226.05%22.93M | 65.48%42.95M | 32.70%24.28M | 26.44%14.61M | 52.54%7.03M | 1,764.22%25.95M | 1,067.12%18.29M | 945.74%11.55M | 301.86%4.61M | 92.63%-1.56M |
| -Interest expense (Financial expense) | 0.02%29.5M | -4.10%119.03M | -4.52%88.87M | -7.52%58.74M | -10.03%29.49M | 9.15%124.12M | 10.96%93.08M | 14.43%63.52M | 19.27%32.78M | 4.35%113.71M |
| -Interest Income (Financial expense) | 62.32%-8.6M | 20.75%-77.97M | 12.74%-65.6M | 13.90%-44.75M | 19.25%-22.82M | 14.91%-98.39M | 12.63%-75.17M | 8.71%-51.97M | 5.19%-28.26M | 12.82%-115.62M |
| Research and development | -30.13%84.28M | 6.95%543.42M | 34.74%420.07M | 34.85%296.92M | 12.10%120.63M | 1.47%508.12M | -13.03%311.77M | -10.06%220.19M | 27.40%107.61M | -37.55%500.75M |
| Credit Impairment Loss | -53.04%-12.21M | -43.78%-42.38M | 8.71%-34.27M | 22.91%-27.8M | 36.86%-7.98M | -130.45%-29.48M | 3.32%-37.53M | 3.88%-36.07M | 7.93%-12.64M | 67.61%-12.79M |
| Asset Impairment Loss | 126.91%6M | 42.19%-133.83M | -23.08%-128.8M | -37.15%-93.67M | -6,352.47%-22.31M | -94.91%-231.52M | -137.65%-104.64M | -58.19%-68.29M | 96.02%-345.73K | 86.75%-118.79M |
| Other net revenue | 139.33%8.89M | 23.02%-130.14M | -66.34%-132.23M | -106.02%-97.09M | -158.73%-22.61M | -512.77%-169.05M | -316.25%-79.5M | -382.42%-47.13M | 2,867.34%38.5M | 104.78%40.96M |
| Fair value change income | --7.6M | 282.99%5.29M | -52.73%441.9K | -93.18%58.3K | --0 | 618.46%1.38M | 672.60%934.77K | 3,401.25%854.67K | --782.67K | -93.95%192.2K |
| Invest income | --124.34K | 224.50%1.51M | -72.08%134.48K | -79.40%99.25K | --0 | -72.62%465.02K | -71.63%481.74K | -71.63%481.74K | ---- | 79.88%1.7M |
| Asset deal income | --0 | 88.90%-934.47K | -2,713.80%-365.8K | -483.69%-365.9K | -360.84%-185.22K | -525.24%-8.42M | 97.40%-13K | -89.10%95.36K | --71.01K | -1,156.20%-1.35M |
| Other revenue | -6.18%7.38M | -59.18%40.21M | -50.04%30.62M | -55.94%24.59M | -84.47%7.86M | -42.72%98.51M | -48.20%61.28M | -41.13%55.8M | 158.80%50.63M | 131.05%171.99M |
| Operating profit | 44.42%40.64M | -78.99%38.07M | -98.27%5.89M | -98.79%1.73M | -59.77%28.14M | -80.90%181.22M | -55.63%341.13M | -74.80%142.69M | -71.38%69.94M | 398.80%948.92M |
| Add:Non operating Income | -57.43%306.43K | 3.36%4.36M | 4.86%3.98M | 13.92%3.7M | 213.88%719.86K | 313.67%4.22M | 604.08%3.79M | 760.18%3.25M | 19.44%229.34K | -84.58%1.02M |
| Less:Non operating expense | -47.34%994.38K | -108.55%-3.04M | -7.60%9.67M | -40.01%5.55M | -62.31%1.89M | 269.22%35.51M | 144.16%10.46M | 211.20%9.26M | 84.13%5.01M | -64.76%9.62M |
| Total profit | 48.13%39.95M | -69.68%45.46M | -99.94%202.3K | -100.09%-121.92K | -58.61%26.97M | -84.05%149.94M | -56.28%334.46M | -75.75%136.69M | -73.05%65.16M | 378.00%940.32M |
| Less:Income tax cost | 38.49%6.35M | 51.93%-24.81M | -194.80%-48.98M | -31.61%-37.72M | -58.81%4.58M | -165.32%-51.62M | -124.45%-16.61M | -153.74%-28.66M | -69.39%11.13M | 138.44%79.02M |
| Net profit | 50.10%33.6M | -65.13%70.27M | -85.99%49.18M | -77.26%37.6M | -58.57%22.39M | -76.60%201.55M | -49.63%351.08M | -67.61%165.35M | -73.70%54.03M | 749.02%861.3M |
| Net profit from continuing operation | 50.10%33.6M | -65.13%70.27M | -85.99%49.18M | -77.26%37.6M | -58.57%22.39M | -76.60%201.55M | -49.63%351.08M | -67.61%165.35M | -73.70%54.03M | 749.02%861.3M |
| Less:Minority Profit | 632.99%261.05K | 42.67%-56.52K | 224.45%24.68K | 335.09%68.17K | -32.48%-48.98K | ---98.57K | ---19.83K | --15.67K | ---36.97K | ---- |
| Net profit of parent company owners | 48.61%33.34M | -65.12%70.33M | -86.00%49.16M | -77.30%37.53M | -58.51%22.43M | -76.59%201.65M | -49.63%351.1M | -67.61%165.34M | -73.69%54.07M | 749.02%861.3M |
| Earning per share | ||||||||||
| Basic earning per share | 50.00%0.03 | -66.67%0.06 | -87.10%0.04 | -80.00%0.03 | -60.00%0.02 | -76.62%0.18 | -50.00%0.31 | -67.39%0.15 | -72.22%0.05 | 741.67%0.77 |
| Diluted earning per share | 50.00%0.03 | -66.67%0.06 | -87.10%0.04 | -80.00%0.03 | -60.00%0.02 | -76.62%0.18 | -50.00%0.31 | -67.39%0.15 | -72.22%0.05 | 741.67%0.77 |
| Other composite income | 36.81%-35.94K | -27.35%-115.81K | 32.21%-93.37K | -76.37%-95.97K | -56.88K | -90.94K | -137.74K | -54.41K | ||
| Other composite income of parent company owners | 36.81%-35.94K | -27.35%-115.81K | 32.21%-93.37K | -76.37%-95.97K | ---56.88K | ---90.94K | ---137.74K | ---54.41K | ---- | ---- |
| Total composite income | 50.32%33.56M | -65.18%70.16M | -86.01%49.09M | -77.31%37.5M | -58.67%22.33M | -76.61%201.46M | -49.65%350.94M | -67.62%165.3M | -73.70%54.03M | 749.02%861.3M |
| Total composite income of parent company owners | 48.83%33.3M | -65.16%70.21M | -86.02%49.06M | -77.35%37.44M | -58.61%22.38M | -76.60%201.56M | -49.65%350.96M | -67.62%165.28M | -73.69%54.07M | 749.02%861.3M |
| Total composite income of minority owners | 632.99%261.05K | 42.67%-56.52K | 224.45%24.68K | 335.09%68.17K | -32.48%-48.98K | ---98.57K | ---19.83K | --15.67K | ---36.97K | ---- |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | ShinWing Certified Public Accountants (Special General Partnership) | -- | -- | -- | ShinWing Certified Public Accountants (Special General Partnership) | -- | -- | -- | ShinWing Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm